Skip to content

Clinical trials

Phase 1 Melanoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1 Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20121
20132
20152
20163
20173
20181
20201
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Boehringer Ingelheim2
Genentech, Inc.2
GlaxoSmithKline2
Hoffmann-La Roche2
Pfizer2
Amgen1
AstraZeneca1
BioNTech US Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma21
Carcinoma, Non-Small-Cell Lung6
Squamous Cell Carcinoma of Head and Neck5
Neoplasms4
Colorectal Neoplasms3
Stomach Neoplasms3
Carcinoma, Renal Cell2
Esophageal Squamous Cell Carcinoma2
Head and Neck Neoplasms2
Kidney Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.